SkinBioTherapeutics plc (AIM: SBTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
17.90
+0.40 (2.29%)
Jan 22, 2025, 1:59 PM GMT+1

SkinBioTherapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Jan '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2016
Market Capitalization
4018223210022
Upgrade
Market Cap Growth
-17.78%-17.78%-31.83%-68.11%353.88%-14.38%
Upgrade
Enterprise Value
401521299419
Upgrade
Last Close Price
0.170.090.130.200.640.17
Upgrade
PS Ratio
26.9714.72163.89424.66--
Upgrade
PB Ratio
11.925.9910.8512.8319.098.90
Upgrade
P/TBV Ratio
--16.7217.1621.2410.72
Upgrade
EV/Sales Ratio
33.0912.45158.92384.18--
Upgrade
Debt / Equity Ratio
0.280.280.050.050.03-
Upgrade
Asset Turnover
0.310.310.050.02--
Upgrade
Inventory Turnover
2.082.080.60---
Upgrade
Quick Ratio
0.630.633.054.1911.917.55
Upgrade
Current Ratio
0.930.933.254.5812.507.70
Upgrade
Return on Equity (ROE)
-115.86%-115.86%-126.84%-72.62%-37.31%-47.80%
Upgrade
Return on Assets (ROA)
-46.50%-46.50%-66.02%-42.26%-22.00%-30.21%
Upgrade
Return on Capital (ROIC)
-61.71%-61.71%-79.79%-46.84%-23.93%-32.27%
Upgrade
Earnings Yield
-16.16%-16.16%-13.10%-8.80%-1.44%-6.84%
Upgrade
FCF Yield
-15.40%-15.40%-12.64%-8.42%-1.56%-4.07%
Upgrade
Buyback Yield / Dilution
-13.10%-13.10%-5.06%-6.87%-14.53%-4.95%
Upgrade
Total Shareholder Return
-13.10%-13.10%-5.06%-6.87%-14.53%-4.95%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.